1-[phenyl-(pyridin-2-yl)methyl]piperazine | 113699-75-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-[phenyl-(pyridin-2-yl)methyl]piperazine
• 英文别名: N-(phenyl-pyridin-2-ylmethyl)piperazine；4-[α-(2-pyridyl)benzyl]piperazine；1-[phenyl-(2-pyridyl)methyl]piperazine；N-(phenyl-2-pyridylmethyl)piperazine；1-[Phenyl(pyridin-2-yl)methyl]piperazine
• CAS: 113699-75-5
• 化学式: C₁₆H₁₉N₃
• 分子量: 253.347
• InChiKey: DFOZOWZBUMYFDD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  28.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-[phenyl-(pyridin-2-yl)methyl]piperazine 生成 5-[3-(4-(phenyl-pyridin-2-ylmethyl)piperazine-1-yl)-2-hydroxypropoxy]quinoline
  参考文献：
  名称：

  Quinoline derivatives

  摘要：

  新颖的杂环化合物，以以下通用公式表示，作为抗癌药物增效剂，对抗癌药物的纳入癌细胞具有增效作用，这些化合物通过例如将由异环化合物与环氧卤水合物反应得到的环氧化合物与胺衍生物反应合成。

  公开号：

  US05112817A1
• 作为产物：
  描述：

  1-苯基-1-(吡啶-2-基)甲醇 在 氯化亚砜 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 反应 1.0h， 生成 1-[phenyl-(pyridin-2-yl)methyl]piperazine
  参考文献：
  名称：

  Design, synthesis, and structure–activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors

  摘要：

  A series of pyrazolo[3,4-d]pyrimidines were synthesized. and their antiviral activity was evaluated in a plaque reduction assay. It is very interesting that this class of compounds provide remarkable evidence that they are very specific for human enteroviruses, in particular, coxsackieviruses. Some derivatives proved to be highly effective in inhibiting enterovirus replication at nanomolar concentrations. SAR studies revealed that the phenyl group at the N-I position and the hydrophobic diarylmethyl group at the piperazine largely influenced the in vitro antienteroviral activity of this new class of potent antiviral agents. It was found that the pyrazolo[3,4-d]pyrimidines with a thiophene substituent, such as compounds 20 24, in general exhibited high activity against coxsackievirus B3 (IC50 = 0.063-0.089 muM) and moderate activity against enterovirus 71 (IC50 = 0.32-0.65 muM) with no apparent cytotoxic effect toward RD (rhabdomyosarcoma) cell lines (CC50>25 muM). (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.02.092

文献信息

• Benzylpiperazine derivative
  申请人：Senju Pharmaceutical Co., Ltd.

  公开号：US05789409A1

  公开（公告）日：1998-08-04

  This invention provides a benzylpiperazine derivative of formula (I) and a pharmacologically acceptable salt thereof ##STR1## wherein R.sub.1 represents a pyridine ring or a group of either formula (IV) or formula (V); R.sub.2 represents hydrogen or lower alkyl ##STR2## wherein R.sub.3 represents hydrogen, lower alkyl, a pyridine ring or a benzene ring which may be substituted by halogen; X represents halogen ##STR3## wherein R.sub.4 and R.sub.5 may be the same or different and each represents hydrogen, lower alkyl, lower alkoxy, halogen or carboxy.

  这项发明提供了一种式(I)的苄基哌嗪衍生物及其药理学上可接受的盐##STR1##其中R.sub.1代表吡啶环或者以下式(IV)或式(V)的基团；R.sub.2代表氢或低碳基##STR2##其中R.sub.3代表氢、低碳基、吡啶环或者可能被卤素取代的苯环；X代表卤素##STR3##其中R.sub.4和R.sub.5可以相同也可以不同，每个代表氢、低碳基、低烷氧基、卤素或羧基。
• Thiazolidinecarboxylic acid amide derivatives and their therapeutic uses
  申请人：Sankyo Company, Limited

  公开号：US05470851A1

  公开（公告）日：1995-11-28

  Thiazolidinecarboxylic acid amides having combined antiallergic and antiasthmatic activities with an antagonist activity against platelet Activating Factor and having the following general formula (I) ##STR1##

  具有联合抗过敏和抗哮喘活性的噻唑烷羧酸酰胺，具有对血小板活化因子的拮抗活性，其一般结构式如下：
• Thiazolidinecarboxylic acid amide derivatives having anti-allergic activity, their preparation and their use
  申请人：Sankyo Company Limited

  公开号：EP0463873A1

  公开（公告）日：1992-01-02

  Compounds of formula (I): [in which R¹ is optionally substituted pyridyl; R² is hydrogen, alkyl or optionally substituted pyridyl; R³ is hydrogen or various organic groups; R⁴ is hydrogen or alkyl; A is alkylene; and Z is a substituted piperidyl, piperazinyl or homopiperazinyl group which is substituted at least by a di-substituted methyl, methoxy or methylene group, each substituent being phenyl or heterocyclyl]; and pharmaceutically acceptable salts thereof have anti-allergic, anti-asthma and anti-PAF activities. Methods of making the compounds are also provided.

  式(I)化合物： [其中 R¹ 是任选取代的吡啶基；R² 是氢、烷基或任选取代的吡啶基；R³ 是氢或各种有机基团；R⁴ 是氢或烷基；A 是亚烷基；和 Z 是至少被二取代甲基、甲氧基或亚甲基取代的取代哌啶基、哌嗪基或均哌嗪基，每个取代基都是苯基或杂环基]；其药学上可接受的盐类具有抗过敏、抗哮喘和抗PAF 活性。还提供了制造这些化合物的方法。
• Benzylpiperazine derivatives as antiallergic and anti-inflammatory agents
  申请人：Senju Pharmaceutical Co., Ltd.

  公开号：EP0753515A2

  公开（公告）日：1997-01-15

  This invention provides a benzylpiperazine derivative of formula (I) and a pharmacologically acceptable salt thereof wherein R1 represents a pyridine ring or a group of either formula (IV) or formula (V); R2 represents hydrogen or lower alkyl. wherein R3 represents hydrogen, lower alkyl, a pyridine ring or a benzene ring which may be substituted by halogen; X represents halogen. wherein R4 and R5 may be the same or different and each represents hydrogen, lower alkyl, lower alkoxy, halogen or carboxy.

  本发明提供了式 (I) 的苄基哌嗪衍生物及其药理学上可接受的盐 其中 R1 代表吡啶环或式（IV）或式（V）的基团； R2 代表氢或低级烷基。 其中 R3 代表氢、低级烷基、吡啶环或可被卤素取代的苯环； X 代表卤素。 其中 R4 和 R5 可以相同或不同，各自代表氢、低级烷基、低级烷氧基、卤素或羧基。
• Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
  申请人：MITSUI TOATSU CHEMICALS, Inc.

  公开号：EP0363212B1

  公开（公告）日：1995-01-04